MEK2, a pivotal component of the MAPK/ERK signaling cascade, possesses a broad influence on various cellular functions, ranging from proliferation to differentiation. The cascading nature of the MAPK/ERK pathway allows several entry points for modulation. The chemicals listed, such as 12-O-Tetradecanoylphorbol-13-acetate (TPA), function by primarily targeting components upstream of MEK2. EGF, for instance, binds to its cognate receptor, EGFR, initiating a signal transduction that culminates in the activation of Raf. Subsequently, Raf phosphorylates and activates MEK2, inducing further downstream effects.
Similarly, other molecules like Anisomycin and Okadaic Acid provide indirect avenues for MEK2 activation. Anisomycin, for instance, exerts its effect through the activation of p38 and JNK pathways. The interplay between these pathways and the Raf/MEK/ERK cascade facilitates MEK2 activation. On the other hand, Okadaic Acid, by inhibiting protein phosphatases, ensures that proteins in the MAPK pathways remain in their phosphorylated state, indirectly maintaining the activated state of MEK2. The presence of such diverse molecules underscores the pathway's centrality in cell signaling. Through various mechanisms, ranging from receptor-ligand interactions to phosphatase inhibition, these molecules converge on a common node, MEK2, emphasizing its critical role in cellular signaling.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
TPA activates Protein Kinase C (PKC) which then can stimulate the Raf/MEK/ERK pathway, leading to the activation of MEK2. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates the p38 and JNK pathways. Cross-talk between these pathways and the Raf/MEK/ERK pathway can lead to MEK2 activation. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
By inhibiting protein phosphatases PP1 and PP2A, Okadaic Acid can maintain or elevate the phosphorylated (active) state of proteins in the MAPK pathways, including MEK2. | ||||||
D-Sorbitol | 50-70-4 | sc-203278A sc-203278 | 100 g 1 kg | $29.00 $69.00 | ||
As an osmolyte, Sorbitol can activate the MAPK pathway through osmotic stress, subsequently leading to MEK2 activation. | ||||||
Angiotensin II, Human | 4474-91-3 | sc-363643 sc-363643A sc-363643B sc-363643C | 1 mg 5 mg 25 mg 100 mg | $51.00 $100.00 $310.00 $690.00 | 3 | |
By activating the AT1 receptor, Angiotensin II can activate several intracellular pathways including the Raf/MEK/ERK cascade, leading to MEK2 activation. | ||||||
Bradykinin | 58-82-2 | sc-507311 | 5 mg | $110.00 | ||
Bradykinin, through its B2 receptor, can activate Phospholipase C, affecting intracellular calcium levels and PKC activation, subsequently influencing the Raf/MEK/ERK pathway and MEK2. | ||||||
Lysophosphatidic Acid | 325465-93-8 | sc-201053 sc-201053A | 5 mg 25 mg | $98.00 $341.00 | 50 | |
LPA can stimulate various GPCRs which can activate the Raf/MEK/ERK pathway and subsequently activate MEK2. | ||||||